| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975257 | The Journal of Heart and Lung Transplantation | 2005 | 4 Pages |
Abstract
Donor lung allograft, with optimized Po2 between 30 and 40 kPa on 100% Fio2, used for lung transplantation did compromise 30-day mortality, but the difference in mortality did not extend beyond 30 days in our patient group.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Heyman (FRCS), Paul PhD, Linda D. PhD, Peter (FRACP), John (FRCS),